TrialAnnals of the rheumatic diseases2013

Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial.

Philip G Conaghan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.